market access Archives -

Novo launches type 2 diabetes pill in UK after NICE waives review

https://pharmaphorum.com/news/novo-launches-type-2-diabetes-pill-in-uk/

https://pharmaphorum.com/news/nice-recommends-regular-nhs-funding-for-roches-lymphoma-drug-polivy/

Roche takes on pricey rivals as FDA approves SMA drug

https://pharmaphorum.com/news/roche-takes-on-pricey-rivals-as-fda-approves-sma-drug/

NICE backs kidney cancer combination from Merck KGaA and Pfizer

https://pharmaphorum.com/news/nice-backs-kidney-cancer-combination-from-merck-kgaa-and-pfizer/

https://pharmaphorum.com/news/nice-backs-nhs-use-for-astellas-xospata-after-rethink/

Windrose Consulting Group acquires Parioforma

https://pharmaphorum.com/partner-content/windrose-consulting-group-acquires-parioforma/

Survey shows patients wait six times longer than EU neighbours for new drugs

https://pharmaphorum.com/news/survey-shows-patients-wait-six-times-longer-than-eu-neighbours-for-new-drugs/

Germany first in EU to get Novartis’ SMA gene therapy, costing almost 2m euros

https://pharmaphorum.com/news/novartis-eyes-smart-deal-for-sma-gene-therapy-in-uk/

NICE rejects Sanofi’s Cablivi for rare blood disorder TTP

https://pharmaphorum.com/news/nice-rejects-sanofis-cablivi-for-rare-blood-disorder-ttp/

Search